Flavopiridol: Developing a Treatment for Resistant Leukemia
Flavopiridol: Developing a Treatment for Resistant Leukemia
Dr. Michael Grever discusses the development of flavopiridol, an investigational cancer drug supported by NCI, and its unexpected effectiveness in the treatment of drug-resistant leukemia and other blood cancers.